Global Medical Marijuana Market is estimated to reach USD 23.5 billion by 2024, registering a CAGR of 25% during the forecast period 2020-2026. Use of marijuana in treatment of arthritis, effectiveness in treatment for neuropathic pain, growing demand for medical marijuana legalization and production of edible products with cannabis are driving the market growth.
The market size reveals a high growth as there is a booming demand for marijuana for therapeutic applications. Rise in prevalence of dreaded diseases is likely to trigger the market growth in the forecast period.

Medical Marijuana Market Trends, Drivers and Opportunities:

Medical Marijuana Market Segment Insights:

By Application:

Based on Distribution Channel:

By Route of Administration:

By Geographical:

Competitive Landscape:

The Colorado Legal Cannabis Market was valued at USD 2.61 Billion in 2024 and is expected to reach USD 5.39 Billion by 2030 with a CAGR of 12.83%.

Germany Legal Cannabis Market was valued at USD 38.23 Million in 2024 and is expected to reach USD 83.41 Million by 2030 with a CAGR of 13.86%.

Market Overview:

The global cannabidiol (CBD) water sales market is expected to grow from USD 1.22 Billion in 2022 to USD 3.81 Billion by 2030, at a CAGR of 14.2% during the forecast period. The growth of this market can be attributed to the increasing legalization of cannabis across the globe, raising awareness about the benefits of CBD Oil, and growing demand for CBD-infused products. Based on type, the global cannabidiol (CBD) water sales market is segmented into Industrial Hemp-derived and Medical Marijuana-derived CBD water segments. The industrial hemp-derived segment is projected to grow at a higher CAGR than the medical marijuana-derived segment during the forecast period. This growth can be attributed to factors such as rising demand for CBD oil from various industries and an increasing number of product launches in this segment.

Product Definition:

Cannabidiol CBD water sales are becoming more and more popular as people learn about the benefits of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid that has been shown to provide relief from a variety of symptoms, including anxiety, pain, and inflammation. CBD oil is available in many forms, but water is one of the most convenient ways to take it.

CBD water can be added to smoothies, juices, or simply drunk straight out of the bottle. It's easy to carry with you on the go and doesn't require any special preparation. Plus, because it's made with purified water and natural ingredients, it's a healthy way to get your daily dose of CBD.

Industrial Hemp-Derived:

Industrial hemp-derived, usage, and growth factor in Cannabidiol (CBD) water sales market is expected to witness significant growth over the forecast period. The growing acceptance of cannabidiol for therapeutic purposes along with its legalization in various countries is anticipated to drive the demand for cannabidiol-based products including CBD water over the forecast period.

Medical Marijuana-Derived:

Cannabidiol (CBD) water is a beverage that contains Cannabidiol (CBD) and is being sold as a dietary supplement. It has become increasingly popular among consumers seeking natural remedies for various health conditions. CBD-infused waters are marketed to treat pain, anxiety, stress, depression and other mental disorders; cancer; fibromyalgia; chronic muscle spasms; epilepsy and other neurological disorders such as Alzheimer’s disease.

Application Insights:

The supermarket was the largest application segment in the global cannabidiol CBD water sales market and accounted for more than 60.0% of the total revenue in 2019. The growth of this segment is attributed to growing awareness about the health benefits associated with CBD consumption coupled with the increasing availability of products in retail stores across the globe.

Offline retail accounted for a significant share owing to high product penetration and wide area coverage by brick-and-mortar retailers, which enables consumers to access to various store locations offering different types of beverages including coffee, tea, soft drinks along with food items. Furthermore, companies such as HempMeds have established strategic partnerships with national brands operating through offline retail channels thereby enabling them access to new markets at a larger scale while providing superior quality products through these partnerships.

Regional Analysis:

North America dominated the global market in terms of revenue share in 2020, followed by Europe. The U.S., being a developed economy and a major consumer of CBD-infused products, held the largest revenue share within North America. The Asia Pacific is expected to grow at the highest rate during the forecast period, owing to increasing investments in CBD-based businesses and raising awareness about its potential benefits. The market in the Asia Pacific is also expected to be highly fragmented, with a number of regional players. Middle East & Africa is projected to witness significant growth over the next five years, as the region emerges as a key player in the global cannabis market. This is due to the increasing legalization of marijuana across various countries in this region, and the growing demand for CBD products among consumers.

Growth Factors:

• Increasing awareness about the health benefits of CBD water among consumers.
• Growing demand for healthy and functional beverages among consumers.
• The rising popularity of CBD-infused products among consumers.
• The an increasing number of online retailers selling CBD water

The global market for cannabidiol (CBD) oil should grow from $967.2 million in 2020 to $5.3 billion by 2025, at CAGR of 40.4% for the period of 2020-2025.

Global Medical Cannabis Market was valued at USD 28.54 billion in 2024 and is expected to reach USD 87.41 billion by 2030 with a CAGR of 20.51%.

Snapshot img

Cannabidiol (CBD) Oil Market Size 2025-2029

The cannabidiol (cbd) oil market size is forecast to increase by USD 8.23 billion at a CAGR of 29.4% between 2024 and 2029.

The CBD oil market is experiencing significant growth, driven by increasing consumption among the millennial population in developed countries and the expanding legalization of cannabis-based products. This demographic trend, coupled with regulatory changes, presents a substantial opportunity for market expansion. However, the market is not without challenges. Adverse effects from overconsumption of CBD oil products, including potential liver damage and interactions with certain medications, pose a risk to consumers and may negatively impact market perception. Companies seeking to capitalize on this market must prioritize product safety and transparency, as well as invest in research and development to address these concerns and differentiate themselves from competitors. Additionally, navigating the complex regulatory landscape and maintaining compliance with varying laws and regulations will be crucial for market success. Overall, the CBD oil market offers significant potential for growth, but companies must address these challenges to effectively capitalize on the opportunities presented.

What will be the Size of the Cannabidiol (CBD) Oil Market during the forecast period?

Request Free SampleThe global CBD business is experiencing significant growth as this non-psychoactive compound derived from cannabis gains popularity for its various uses in treatments and consumer goods. Key market drivers include the legalization of CBD in several regions and the increasing acceptance of cannabidiol acids in medications, personal care items, and health and beauty products. CBD-based products come in various forms, including oils, capsules, transdermal patches, and vaping devices. Producers are continually refining manufacturing processes and testing methodologies to meet consumer demands for high-quality, safe products. Government measures and regulatory processes play a crucial role in shaping the market dynamics. For instance, stricter regulations on vaping devices have led to a shift towards other delivery methods like body lotions and tinctures. Consumer attitudes towards cannabis and related complications also influence the market trends. As more people turn to CBD for pain relief, anxiety reduction, and other health benefits, the demand for CBD-based treatments continues to rise. The variety of uses for CBD extends beyond human applications. Producers are exploring opportunities in pet care and pharmaceuticals, further expanding the market's reach. Processing techniques and cannabis strains with high CBD content are under constant development to cater to the evolving consumer preferences and regulatory requirements.

How is this Cannabidiol (CBD) Oil Industry segmented?

The cannabidiol (cbd) oil industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductMarijuana derived CBD oilHemp derived CBD oilApplicationPharmaceuticalsPersonal care and cosmeticsFood and beveragesWellnessGeographyNorth AmericaUSCanadaAPACChinaIndiaJapanSouth KoreaEuropeFranceGermanyItalyUKSouth AmericaMiddle East and Africa

By Product Insights

The marijuana derived cbd oil segment is estimated to witness significant growth during the forecast period.CBD oil derived from marijuana is gaining popularity among consumers due to its broader range of therapeutic components, including cannabinoids, terpenes, and other chemicals found in the cannabis plant. Known as full-spectrum CBD oil, this product is believed to have an entourage effect, where the synergistic interaction of these components enhances the overall therapeutic benefits of CBD. The potential medicinal advantages of marijuana-derived CBD oil, such as pain relief, anxiety reduction, and potential anti-inflammatory properties, are driving demand for this product. As research progresses and more information becomes available, consumer acceptance of marijuana-derived CBD oil as a natural remedy for various health conditions continues to grow. This trend is not limited to humans but extends to pets and health and beauty industries, with CBD-based products being used in medical therapies, cosmetics, and personal care items. The legalization of marijuana and CBD in several countries and regions is further fueling the global CBD business, leading to the development of new manufacturing processes and products, such as capsules, tinctures, transdermal patches, and inhalation devices. Governments and regulatory bodies are implementing measures to ensure health safety assurance and consumer-facing openness, while producers are focusing on Food Grade and Therapeutic Grade qualit

Cannabinoid-based Products for Cancer Market Outlook

The global market size for cannabinoid-based products for cancer is projected to grow significantly from USD 1.2 billion in 2023 to an estimated USD 3.8 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 13.5%. Key growth factors driving this market include increasing research on the therapeutic benefits of cannabinoids, rising cancer prevalence, and growing patient acceptance of alternative treatments.

One of the primary growth factors propelling the market is the expanding body of research supporting the efficacy of cannabinoids in cancer treatment. Numerous clinical trials and scientific studies have demonstrated that cannabinoids such as CBD and THC can alleviate cancer-related symptoms like pain, nausea, and loss of appetite. These findings are not only bolstering the demand for cannabinoid-based products but are also leading to increased funding and investments in cannabinoid research. The growing acceptance of medical marijuana and the loosening of regulatory restrictions in various countries are also contributing to the favorable environment for these products.

Another crucial driver for the market is the increasing incidence of cancer globally. According to the World Health Organization (WHO), cancer is one of the leading causes of death, with approximately 19.3 million new cases and 10 million cancer-related deaths in 2020 alone. As the prevalence of cancer continues to rise, there is a corresponding increase in demand for effective and holistic treatment options. Cannabinoid-based products are increasingly being integrated into comprehensive cancer care plans, providing symptom relief and improving patients' quality of life.

The growing trend towards personalized medicine is another significant factor contributing to market growth. Patients and healthcare providers are seeking treatments tailored to individual needs and conditions, and cannabinoid-based products offer a customizable approach to symptom management. Advances in biotechnology and pharmacology are enabling the development of cannabinoid formulations that can be precisely dosed and targeted for specific therapeutic effects. This personalized approach is gaining traction, particularly in oncology, where managing side effects and improving patient comfort are critical components of treatment.

From a regional perspective, North America is anticipated to dominate the cannabinoid-based products for cancer market, owing to the high acceptance of medical cannabis, robust research infrastructure, and favorable regulatory landscape. Europe is also expected to show significant growth due to increasing legalization and the strong presence of pharmaceutical companies investing in cannabinoid research. In contrast, regions like Asia Pacific, Latin America, and the Middle East & Africa are poised to see accelerated growth as awareness increases and regulatory frameworks evolve.

Product Type Analysis

The cannabinoid-based products for cancer market can be segmented by product type into CBD Oil, THC Oil, Capsules, Edibles, Topicals, and Others. Each of these product types offers unique benefits and faces distinct market dynamics, contributing to the diverse landscape of cannabinoid-based therapies.

CBD Oil is one of the most popular product types in this market, primarily due to its non-psychoactive properties and wide range of therapeutic benefits. Studies have shown that CBD oil can help reduce pain, inflammation, and anxiety, making it a valuable addition to cancer care regimens. The demand for CBD oil is further boosted by its versatility, as it can be administered orally, sublingually, or topically, providing patients with various options for consumption. Moreover, the growing trend towards natural and organic products is favoring the adoption of CBD oil.

THC Oil, containing the psychoactive compound tetrahydrocannabinol, is another significant segment. While it is often associated with recreational use, THC oil has demonstrated effectiveness in managing severe pain and stimulating appetite in cancer patients. However, its psychoactive effects can be a limiting factor for some patients and healthcare providers. Despite this, ongoing research and product development are focused on minimizing these side effects while enhancing the therapeutic benefits of THC oil.

Capsules and edibles represent convenient and discreet options for patients who prefer not to use oils or topicals. These product forms offer precise dosing, which is crucial for manag

According to Cognitive Market Research, the Global Glufosinate Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

Based on Crop Type, the cereals and grains segment will dominate the global Glufosinate market in the year 2023. Based on crop type, the market is divided into Cereals and Grains, Oilseeds and Pulses, Fruits and Vegetables, Others
Based on Application, the Herbicide segment dominated the global Glufosinate market. Based on Application, the global Glufosinate market is segmented into Herbicide, Plant Breeding, Liquid Chromatography, and Others.
Based on End-users, the Agriculture segment dominated the global Glufosinate market. Based on End-users, the global Glufosinate market is segmented into Agriculture, Bio-Medical and Bio-Technology, Pharmaceutical, Environment, and Others.
Based on Form, the Liquid segment dominated the global Glufosinate market. Based on form, the global Glufosinate market is segmented into Liquid, and Solid - Dry.
The Asian-Pacific region accounted for the highest market share in the Global Glufosinate Market. 
Over the course of the projection period, North America is expected to increase at the fastest rate.

CURRENT SCENARIO OF THE GLUFOSINATE MARKET

Key factors driving the growth of the Glufosinate Market

Increasing agricultural activities to contribute towards market growth

Due to its broad-spectrum herbicide's ability to effectively control a variety of weeds, glufosinate has attracted a lot of attention from the agricultural world. Its mechanism of action interferes with the plant's capacity to make vital amino acids, which effectively and quickly controls weeds. Due to its favourable environmental properties, including its low persistence and soil mobility, glufosinate is a favoured option for farmers looking for environmentally friendly weed control methods.

Key growth drivers for the glufosinate market have emerged as regions including Asia-Pacific, Latin America, and parts of Africa that are going through tremendous agricultural expansion. In order to guarantee effective weed control and optimise crop yield, these regions have seen a rise in the use of herbicidal solutions due to the adoption of modern farming practices and growing farm sizes.

The need for effective weed management solutions grows as agricultural techniques change to suit the demands of a growing population and shifting climatic circumstances. In light of this, glufosinate becomes an essential weapon in the toolbox of contemporary farmers, propelling continual expansion and innovation in the agrochemical industry.

Growing agricultural activities owing to the need and requirement of the rapidly increasing population will act as a driving factor for the glufosinate market. For instance, in China, the agriculture industry constantly rises every year by at least 2.3%, which accounted for about USD 734.9 billion in the first three quarters and recorded nearly 670 billion kg in 2020, which marks the sixth consecutive year for China’s total food grain production that has crossed over 650 billion kg. (Source: https://www.fao.org/3/ab981e/ab981e0c.htm)

These kinds of increases in agricultural activities and demand for genetically modified crops owing to their cost-effective characteristic and weed controlling properties will boost the growth of the glufosinate market globally.

Increasing Demand for Alternative Substitutes for Glyphosate Herbicide and Government support and initiatives propelling market growth

Herbicides containing glufosinate are increasingly used by farmers as a plant protection measure. When glyphosate ammonium gets into contact with plants, it works better to control weeds without harming the soil, roots, or necessitating tillage. When used in conjunction with an integrated weed management programme (IWM), it also contributes to the development of resistance to other herbicides, hence increasing the use of glufosinate.

Furthermore, a lot of businesses are creating various items to expand their market by knowing the demand for glufosinate.

The BASF SE, a European-based multinational company, and the largest chemical producer in the world has offered glufosinate-ammonium as an active ingredient in several herbicide products such as Basta, Finale, Rely and Liberty. The wide...

The Agricultural Harvester Market size was valued at USD 31 Million in 2023 and is projected to reach USD 48 Million by 2032, exhibiting a CAGR of 3.70 % during the forecasts periods. This growth stems from: Recent developments include: November 2022: CLAAS invested USD 48.4 million in producing the world's first modern combined harvester at its Harsewinkel site as part of the SynPro 2020 project. The company aims to manufacture a harvester with unparalleled variety and highly flexible production with significant CO2 savings., March 2021: Kubota Corporation announced its decision to increase its shareholding by 2022 in the Indian tractor manufacturing company Escorts Limited to develop and manufacture basic combined harvesters targeting India and other emerging markets.. Key drivers for this market are: Increasing Legalization of Cannabis, Growing Focus on Health Benefits of Cannabis. Potential restraints include: Lack of Data on Dosages and Results, Lack of Access to Financial Assistance. Notable trends are: Labor Shortage and Rising Cost of Farm Labor.

Global Hemp Fiber Market was valued at USD 378.56 million in 2024 and is expected to reach USD 561.80 million by 2030 with a CAGR of 7.00% during the forecast period.